LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,370,140 | -26.3% | 56,244 | -11.3% | 0.00% | – |
| Q2 2023 | $4,570,203 | +17.2% | 63,387 | +19.6% | 0.00% | -100.0% |
| Q1 2023 | $3,899,268 | +166.3% | 53,008 | +141.8% | 0.00% | – |
| Q4 2022 | $1,464,189 | -78.2% | 21,919 | -71.9% | 0.00% | -100.0% |
| Q3 2022 | $6,718,000 | +133.1% | 78,024 | +141.6% | 0.00% | 0.0% |
| Q2 2022 | $2,882,000 | -62.5% | 32,300 | -52.8% | 0.00% | 0.0% |
| Q1 2022 | $7,693,000 | -78.3% | 68,382 | -70.2% | 0.00% | 0.0% |
| Q4 2021 | $35,438,000 | +112.3% | 229,442 | +91.5% | 0.00% | -50.0% |
| Q3 2021 | $16,691,000 | -50.5% | 119,804 | -53.4% | 0.00% | -60.0% |
| Q2 2021 | $33,742,000 | -6.2% | 257,199 | +9.0% | 0.01% | -16.7% |
| Q1 2021 | $35,964,000 | -40.1% | 235,905 | -60.9% | 0.01% | +20.0% |
| Q4 2020 | $60,058,000 | +531.5% | 603,890 | +505.3% | 0.01% | +150.0% |
| Q3 2020 | $9,511,000 | -60.3% | 99,767 | -53.4% | 0.00% | -60.0% |
| Q2 2020 | $23,956,000 | +61.0% | 214,166 | +4.7% | 0.01% | 0.0% |
| Q1 2020 | $14,877,000 | -44.1% | 204,582 | -19.8% | 0.01% | -37.5% |
| Q4 2019 | $26,590,000 | -47.9% | 254,950 | -50.3% | 0.01% | -52.9% |
| Q3 2019 | $51,046,000 | -79.9% | 512,815 | -76.9% | 0.02% | -45.2% |
| Q2 2019 | $253,448,000 | +172.5% | 2,220,315 | +200.1% | 0.03% | -18.4% |
| Q1 2019 | $93,004,000 | +90.9% | 739,833 | +106.0% | 0.04% | +100.0% |
| Q4 2018 | $48,730,000 | +16.7% | 359,100 | +136.1% | 0.02% | +46.2% |
| Q3 2018 | $41,752,000 | +62.8% | 152,107 | +22.9% | 0.01% | +44.4% |
| Q2 2018 | $25,641,000 | +75.0% | 123,768 | +39.5% | 0.01% | +125.0% |
| Q1 2018 | $14,656,000 | +638.0% | 88,742 | +512.0% | 0.00% | – |
| Q4 2017 | $1,986,000 | -27.1% | 14,500 | -27.5% | 0.00% | -100.0% |
| Q3 2017 | $2,723,000 | -79.5% | 20,000 | -81.8% | 0.00% | -66.7% |
| Q2 2017 | $13,305,000 | +21.6% | 109,600 | +6.0% | 0.01% | 0.0% |
| Q1 2017 | $10,944,000 | -74.9% | 103,400 | -75.9% | 0.01% | -72.7% |
| Q4 2016 | $43,527,000 | +351.3% | 428,369 | +353.3% | 0.02% | +450.0% |
| Q3 2016 | $9,644,000 | +85.5% | 94,500 | +116.7% | 0.00% | +33.3% |
| Q2 2016 | $5,200,000 | -10.2% | 43,600 | -19.4% | 0.00% | 0.0% |
| Q1 2016 | $5,793,000 | +13.8% | 54,100 | +15.2% | 0.00% | +50.0% |
| Q4 2015 | $5,092,000 | -48.9% | 46,967 | -59.7% | 0.00% | -60.0% |
| Q3 2015 | $9,972,000 | -31.6% | 116,413 | -19.4% | 0.01% | -16.7% |
| Q2 2015 | $14,580,000 | +87.5% | 144,498 | +43.3% | 0.01% | +100.0% |
| Q1 2015 | $7,774,000 | +154.1% | 100,817 | +75.3% | 0.00% | +200.0% |
| Q4 2014 | $3,060,000 | -63.6% | 57,526 | -67.8% | 0.00% | -66.7% |
| Q3 2014 | $8,403,000 | -30.4% | 178,835 | -7.7% | 0.00% | -50.0% |
| Q2 2014 | $12,070,000 | +51.1% | 193,766 | +63.1% | 0.01% | +100.0% |
| Q1 2014 | $7,990,000 | -8.8% | 118,786 | -28.7% | 0.00% | -25.0% |
| Q4 2013 | $8,763,000 | +563.9% | 166,589 | +446.2% | 0.00% | – |
| Q3 2013 | $1,320,000 | +378.3% | 30,500 | +313.7% | 0.00% | – |
| Q2 2013 | $276,000 | – | 7,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |